← Leaderboards
Chris L. Coleman
Chrysalis Biotechnology, Inc.
$450,303
Attributed
$450,303
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$450,303 · 3
By mechanism
R43$450,303 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Thrombin”
- Enrico Di Cera · Washington University$25,990,132
- Athan Kuliopulos · Tufts Medical Center$21,847,000
- Nigel Mackman · Univ Of North Carolina Chapel Hill$19,107,575
- Zaverio M Ruggeri · Scripps Research Institute$18,391,618
- Erik Ian Tucker · Aronora, Inc.$16,899,000
- Alireza R. Rezaie · Saint Louis University$14,423,469
Research focus
ThrombinDrug Design /Synthesis /ProductionAntibacterial AgentsBinding (Molecular Function)Biotherapeutic AgentBloodBreast Cancer CellCardiovascular AgentsCancer CellCancer Cell LineCancer CenterCancer Death RatesCancer PatientCancer TherapyCancer TypeBlood CirculationCause Of DeathCellsCessation Of LifeChemotaxisChemotherapyChorioallantoic MembraneCirculating Cancer CellAntiinfective Agents